Drug-induced osteonecrosis of the jaw: how to prevent and treat
DOI:
https://doi.org/10.33448/rsd-v11i12.34568Keywords:
Antiresorptive drugs; Bisphosphonates; Denozumab; Drug-related osteonecrosis of the jaws; Osteoradionecrosis of the jaws.Abstract
Specific bone structures (BSDs) are critical in treating bone density, bone fractures or metastases. They can be classified as anti-resorptive or anabolic. ONJ was first associated with bisphosphonate treatment in 203, and is now recognized as an adverse effect of bisphosphonate and other BSD treatment. In this sense, this study aimed to review the literature on drug-induced osteonecrosis of the jaws, addressing diagnostic methods, as well as prevention and treatment protocols for this disease. For the construction of this article, a bibliographic survey was carried out in the databases SciVerse Scopus, Scientific Electronic Library Online (Scielo), U.S. National Library of Medicine (PUBMED) and ScienceDirect, with the help of the Mendeley reference manager. Articles Osteonecrosis between the years 2022.lars to drug-induced maxi-drug therapy, but were too necrosis for a therapy, of adverse drug consequence, but were too necrosis for a PB therapy of adverse effects. It is mainly associated with the use of more potent bisphosphonate amino acids for long periods of time. The most important antecedent event to the development of clinics is invasive dental treatment, therefore, it is important for ordinary oral health professionals to have an understanding of its causes and management. The most important aspect of the treatment starts at the time of the first preparation and must continue for the life-restoring effect of the patient due to the continued effect of the drugs on the bone.
References
Referências
Akashi, M., Wanifuchi, S., Iwata, E., Takeda, D., Kusumoto, J., Furudoi, S., & Komori, T. (2018). Differences between osteoradionecrosis and medication-related osteonecrosis of the jaw. Oral and Maxillofacial Surgery, 22(1), 59–63. https://doi.org/10.1007/s10006-017-0667-5
Beth-Tasdogan, N. H., Mayer, B., Hussein, H., & Zolk, O. (2017). Interventions for managing medication-related osteonecrosis of the jaw. The Cochrane Database of Systematic Reviews, 10(10), CD012432. https://doi.org/10.1002/14651858.CD012432.pub2
Campisi, G., Mauceri, R., Bertoldo, F., Bettini, G., Biasotto, M., Colella, G., Consolo, U., Di Fede, O., Favia, G., Fusco, V., Gabriele, M., Lo Casto, A., Lo Muzio, L., Marcianò, A., Mascitti, M., Meleti, M., Mignogna, M. D., Oteri, G., Panzarella, V., & Bedogni, A. (2020). Medication-Related Osteonecrosis of Jaws (MRONJ) Prevention and Diagnosis: Italian Consensus Update 2020. In International journal of environmental research and public health (Vol. 17, Issue 16). https://doi.org/10.3390/ijerph17165998
Cardona, F., Bagán, J. V, Sáinz, E., Figuerido, J., Giner, F., & Vidán, F. J. (2009). [Bisphosphonate-related osteonecrosis of the jaws. An update]. Anales del sistema sanitario de Navarra, 32(3), 413–421. https://doi.org/10.23938/ASSN.0138
Colella, G., Campisi, G., & Fusco, V. (2009). American Association of Oral and Maxillofacial Surgeons Position Paper: Bisphosphonate-Related Osteonecrosis of the Jaws—2009 Update: The Need to Refine the BRONJ Definition. Journal of Oral and Maxillofacial Surgery, 67(12), 2698–2699. https://doi.org/https://doi.org/10.1016/j.joms.2009.07.097
Ghidini, G., Manfredi, M., Giovannacci, I., Mergoni, G., Sarraj, A., Mureddu, M., Giunta, G., Bonanini, M., Meleti, M., & Vescovi, P. (2017). Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs. Minerva Stomatologica, 66(4), 135–140. https://doi.org/10.23736/S0026-4970.17.04056-0
Gómez, G. J. Á., Camacho, R. V. L., Torres, J. E. B., Gómez, S. M. B., Álzate, D. P. C., Ross, P. A. C., & Arévalo, J. E. H. (2017). Alterations found in the mouth of patients treated with head and neck radiotherapy. Medellin, Colombia. Revista Odontológica Mexicana, 21(2), e86–e96. https://doi.org/https://doi.org/10.1016/j.rodmex.2017.05.012
Hillner, B. E., Ingle, J. N., Berenson, J. R., Janjan, N. A., Albain, K. S., Lipton, A., Yee, G., Biermann, J. S., Chlebowski, R. T., & Pfister, D. G. (2000). American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 18(6), 1378–1391. https://doi.org/10.1200/JCO.2000.18.6.1378
Khan, A. A., Morrison, A., Hanley, D. A., Felsenberg, D., McCauley, L. K., O’Ryan, F., Reid, I. R., Ruggiero, S. L., Taguchi, A., Tetradis, S., Watts, N. B., Brandi, M. L., Peters, E., Guise, T., Eastell, R., Cheung, A. M., Morin, S. N., Masri, B., Cooper, C., & Compston, J. (2015). Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. Journal of Bone and Mineral Research : The Official Journal of the American Society for Bone and Mineral Research, 30(1), 3–23. https://doi.org/10.1002/jbmr.2405
Khan, A. A., Morrison, A., Kendler, D. L., Rizzoli, R., Hanley, D. A., Felsenberg, D., McCauley, L. K., O’Ryan, F., Reid, I. R., Ruggiero, S. L., Taguchi, A., Tetradis, S., Watts, N. B., Brandi, M. L., Peters, E., Guise, T., Eastell, R., Cheung, A. M., Morin, S. N., & Compston, J. (2017). Case-Based Review of Osteonecrosis of the Jaw (ONJ) and Application of the International Recommendations for Management From the International Task Force on ONJ. Journal of Clinical Densitometry : The Official Journal of the International Society for Clinical Densitometry, 20(1), 8–24. https://doi.org/10.1016/j.jocd.2016.09.005
Khan, A., Morrison, A., Cheung, A., Hashem, W., & Compston, J. (2016). Osteonecrosis of the jaw (ONJ): diagnosis and management in 2015. Osteoporosis International : A Journal Established as Result of Cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 27(3), 853–859. https://doi.org/10.1007/s00198-015-3335-3
Kün-Darbois, J.-D., & Fauvel, F. (2021). Medication-related osteonecrosis and osteoradionecrosis of the jaws: Update and current management. Morphologie, 105(349), 170–187. https://doi.org/https://doi.org/10.1016/j.morpho.2020.11.008
Kün-Darbois, J. D., & Fauvel, F. (2021). Medication-related osteonecrosis and osteoradionecrosis of the jaws: Update and current management. Morphologie, 105(349), 170–187. https://doi.org/10.1016/j.morpho.2020.11.008
McLeod, N. M. H., Brennan, P. A., & Ruggiero, S. L. (2012). Bisphosphonate osteonecrosis of the jaw: A historical and contemporary review. The Surgeon, 10(1), 36–42. https://doi.org/https://doi.org/10.1016/j.surge.2011.09.002
Nordström, P., Bergman, J., Ballin, M., Björk, S., & Nordström, A. (2020). Bone-Specific Drugs and Osteonecrosis of Sites Other Than the Jaw: A Nationwide Cohort Study. Journal of Bone and Mineral Research : The Official Journal of the American Society for Bone and Mineral Research, 35(9), 1703–1710. https://doi.org/10.1002/jbmr.4040
Otto, S., Pautke, C., Van den Wyngaert, T., Niepel, D., & Schiødt, M. (2018). Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases. Cancer Treatment Reviews, 69, 177–187. https://doi.org/10.1016/j.ctrv.2018.06.007
Pan, J., & Liu, J.-Y. (2021). Mechanism, prevention, and treatment for medication-related osteonecrosis of the jaws. Hua Xi Kou Qiang Yi Xue Za Zhi = Huaxi Kouqiang Yixue Zazhi = West China Journal of Stomatology, 39(3), 245–254. https://doi.org/10.7518/hxkq.2021.03.001
Santos, P. S. S., Gambirazi, L. M., Felix, V. B., & Magalhães, M. H. C. G. (2008). Osteonecrose maxilar em pacientes portadores de doenças neoplásicas sob uso de bisfosfonatos. Revista Brasileira de Hematologia e Hemoterapia, 30(6), 0–3. https://doi.org/10.1590/s1516-84842008000600016
Shah, S. A. A., Aslam, A., Mirza, A. I., & Ali, S. (2010). Bisphosphonate related osteonecrosis of the jaws. Journal of Ayub Medical College, Abbottabad : JAMC, 22(3), 214–217.
Svejda, B., Muschitz, C., Gruber, R., Brandtner, C., Svejda, C., Gasser, R. W., Santler, G., & Dimai, H. P. (2016). [Position paper on medication-related osteonecrosis of the jaw (MRONJ)]. Wiener medizinische Wochenschrift (1946), 166(1–2), 68–74. https://doi.org/10.1007/s10354-016-0437-2
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Nívia Delamoniky Lima Fernandes ; Geovana Martins Lopes; Marcelo Costa Rodrigues ; Grace Kelly Martins Carneiro ; Kaio Henrique da Silva Carneiro ; Geraldo Soprani Júnior; Flávia Renata de Oliveira; Isabella Pulino Padilha; Ingrid Bruna de Menezes Rabelo ; Genilson Campos da Silva
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
